Status:
COMPLETED
Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration
Lead Sponsor:
University of Illinois at Chicago
Conditions:
Retinal Degenerations
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A small percentage of patients with retinal degeneration accumulate fluid in the center of their retina. Previous studies using an oral form of treatment has been successful in decreasing this fluid ...
Detailed Description
Patients with certain retinal degenerations will be asked to take part in a research study about the use of a topically applied eye drop for treating fluid in the central part of the retina (macular e...
Eligibility Criteria
Inclusion
- Presence of cystic macular fluid on OCT testing
Exclusion
- Allergic reaction to sulpha containing compounds
- Intolerance to dorzolamide (Trusopt)
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 17 2017
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00716586
Start Date
October 1 2005
End Date
November 17 2017
Last Update
October 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois Medical Center
Chicago, Illinois, United States, 60612